The Michael J. Fox Foundation - Novel PET Tracer Development Program | Research Funding

This program supports work to develop and validate PET imaging techniques utilizing radiotracers of a variety of disease-relevant targets that can ultimately be implemented in clinical practice and clinical trials for Parkinson’s Disease. 
 

• Projects of interest include early screening efforts and early in vitro and in vivo validation of newly developed tracers. 
   
• Targets of interest include, but are not limited to, pathologic proteins, inflammation (astrocytes, NLRP3, microglia, etc.) and other therapeutic targets (neuronal receptors, GBA, mitochondria, etc.). 
   
• Projects should aim to develop novel PET tracers as opposed to collecting data using existing tracers. 
   
• For this round, MJFF will not consider proposals focused on human studies. 

• U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
   
• U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
   
• Post-doctoral fellows are eligible to apply as co-investigators with the designation of an administrative primary investigator who directs the laboratory in which the fellow will conduct research.

• More information about the program is available here
• The application portal can be found here
• For any other questions, please contact the Research Office